TIAA FSB’s Edwards Lifesciences EW Stock Holding History

TIAA FSB’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$935K	Sell	9,915 -13	-0.1%	-$1.13K	﹤0.01%	333
2023 Q1	$821K	Sell	9,928 -1,394	-12%	-$110K	﹤0.01%	342
2022 Q4	$845K	Sell	11,322 -87,668	-89%	-$6.76M	﹤0.01%	338
2022 Q3	$8.18M	Sell	98,990 -8,689	-8%	-$836K	0.04%	171
2022 Q2	$10.2M	Buy	107,679 +6,874	+7%	+$712K	0.04%	152
2022 Q1	$11.9M	Buy	100,805 +2,620	+3%	+$294K	0.04%	153
2021 Q4	$12.7M	Sell	98,185 -751	-0.8%	-$87.6K	0.04%	150
2021 Q3	$11.2M	Sell	98,936 -8,657	-8%	-$988K	0.04%	154
2021 Q2	$11.1M	Buy	107,593 +95,389	+782%	+$8.99M	0.04%	158
2021 Q1	$1.02M	Buy	12,204 +289	+2%	+$24.4K	﹤0.01%	300
2020 Q4	$1.09M	Buy	+11,915	New	+$988K	﹤0.01%	288

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TIAA FSB's EW Position: Q2 2023 in Review

TIAA FSB reduced its Edwards Lifesciences (EW) stake by 0.13% in Q2 2023, selling an estimated $1.13K and leaving 9,915 shares worth $935K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

TIAA FSB first reported a position in EW in Q4 2020 and has held it in 11 quarters since. The position peaked at $12.7M in Q4 2021. 1,278 funds tracked by Wall St. Rank hold EW as of Q2 2023.

TIAA FSB held 9,915 shares of Edwards Lifesciences worth $935K as of Q2 2023.
TIAA FSB sold 13 Edwards Lifesciences shares in Q2 2023, an estimated $1.13K.
Edwards Lifesciences made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #333 holding.
TIAA FSB first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 11 quarters since.
TIAA FSB's Edwards Lifesciences position peaked at $12.7M in Q4 2021.
1,278 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.